HomeTCRT • NASDAQ
add
Alaunos Therapeutics Inc
Previous close
$0.64
Day range
$0.60 - $0.64
Year range
$0.60 - $7.65
Market cap
10.21M USD
Avg Volume
39.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.00K | — |
Operating expense | 1.62M | -48.96% |
Net income | -1.68M | 83.26% |
Net profit margin | -168.20K | — |
Earnings per share | — | — |
EBITDA | -1.74M | 80.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.14M | -82.36% |
Total assets | 6.04M | -87.59% |
Total liabilities | 1.24M | -93.52% |
Total equity | 4.80M | — |
Shares outstanding | 16.01M | — |
Price to book | 2.12 | — |
Return on assets | -60.91% | — |
Return on capital | -78.44% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.68M | 83.26% |
Cash from operations | -1.92M | 79.57% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.92M | 87.68% |
Free cash flow | -1.32M | 77.38% |
About
Founded
1998
Website
Employees
1